Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease
Lars Tönges, Tobias Frank, Lars Tatenhorst, et al.
Brain (2012) Vol. 135, Iss. 11, pp. 3355-3370
Open Access | Times Cited: 168

Showing 1-25 of 168 citing articles:

Rho family GTPases: key players in neuronal development, neuronal survival, and neurodegeneration
Trisha R. Stankiewicz, Daniel A. Linseman
Frontiers in Cellular Neuroscience (2014) Vol. 8
Open Access | Times Cited: 338
Axon growth inhibition by RhoA/ROCK in the central nervous system
Yuki Fujita, Toshihide Yamashita
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 241
Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes
Hannah Scheiblich, Cira Dansokho, Dilek Mercan, et al.
Cell (2021) Vol. 184, Iss. 20, pp. 5089-5106.e21
Open Access | Times Cited: 237
ROCK inhibition in models of neurodegeneration and its potential for clinical translation
Jan Christoph Koch, Lars Tatenhorst, Anna‐Elisa Roser, et al.
Pharmacology & Therapeutics (2018) Vol. 189, pp. 1-21
Open Access | Times Cited: 190
RhoA Signaling in Neurodegenerative Diseases
Sissel Ida Schmidt, Morten Blaabjerg, Kristine Freude, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1520-1520
Open Access | Times Cited: 74
ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS
Jan Christoph Koch, Lars Tönges, Elisabeth Barski, et al.
Cell Death and Disease (2014) Vol. 5, Iss. 5, pp. e1225-e1225
Open Access | Times Cited: 174
Rho Kinases in Health and Disease: From Basic Science to Translational Research
Gervaise Loirand
Pharmacological Reviews (2015) Vol. 67, Iss. 4, pp. 1074-1095
Open Access | Times Cited: 172
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
Karen Litwa, Rick Horwitz, Marcelo Lazzaron Lamers
Disease Models & Mechanisms (2015)
Open Access | Times Cited: 154
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Lars Tatenhorst, Katrin Eckermann, Vivian Dambeck, et al.
Acta Neuropathologica Communications (2016) Vol. 4, Iss. 1
Open Access | Times Cited: 140
Leaky brain in neurological and psychiatric disorders: Drivers and consequences
Gerwyn Morris, Brisa S. Fernandes, Basant K. Puri, et al.
Australian & New Zealand Journal of Psychiatry (2018) Vol. 52, Iss. 10, pp. 924-948
Open Access | Times Cited: 121
The renin–angiotensin system: a possible new target for depression
João Vian, C. Lopes Pereira, V. Chavarría, et al.
BMC Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 118
ROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway
Natalia Moskal, Victoria Riccio, Mikhail Bashkurov, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 112
Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis
Lars Tönges, René Günther, Martin Suhr, et al.
Glia (2013) Vol. 62, Iss. 2, pp. 217-232
Closed Access | Times Cited: 109
Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson’s disease animal model
Atsushi Fujita, Hiroo Yamaguchi, Ryo Yamasaki, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 100
The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders
Jessica Eira, Catarina S. Silva, Mónica Mendes Sousa, et al.
Progress in Neurobiology (2016) Vol. 141, pp. 61-82
Closed Access | Times Cited: 99
Updates on immunity and inflammation in Parkinson disease pathology
Neeraj Joshi, Sarika Singh
Journal of Neuroscience Research (2017) Vol. 96, Iss. 3, pp. 379-390
Open Access | Times Cited: 99
Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson’s Disease through Activating Mitophagy
Ming‐Wei Lin, Chi‐Chen Lin, Yi‐Hung Chen, et al.
Antioxidants (2019) Vol. 9, Iss. 1, pp. 37-37
Open Access | Times Cited: 87
Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson’s disease (ROCK-PD)
Andreas Wolff, Helen Bidner, Yvonne Remane, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 8
SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants
Andreas Wolff, Jörg Peine, Josef Höfler, et al.
CNS Drugs (2024) Vol. 38, Iss. 4, pp. 291-302
Open Access | Times Cited: 8
Interaction between NADPH‐oxidase and Rho‐kinase in angiotensin II‐induced microglial activation
Ana I. Rodríguez‐Pérez, Ana Borrajo, Jannette Rodríguez‐Pallares, et al.
Glia (2014) Vol. 63, Iss. 3, pp. 466-482
Closed Access | Times Cited: 87
Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?
Meihui Chen, Anmin Liu, Ying Ouyang, et al.
Expert Opinion on Investigational Drugs (2013) Vol. 22, Iss. 4, pp. 537-550
Closed Access | Times Cited: 87
Effect and Reporting Bias of RhoA/ROCK-Blockade Intervention on Locomotor Recovery After Spinal Cord Injury
Ralf Watzlawick, Emily S. Sena, Ulrich Dirnagl, et al.
JAMA Neurology (2013) Vol. 71, Iss. 1, pp. 91-91
Closed Access | Times Cited: 85
Studying neurodegenerative diseases in culture models
Johannes C. M. Schlachetzki, Soraya Wilke Saliba, Antônio Carlos Pinheiro de Oliveira
Brazilian Journal of Psychiatry (2013) Vol. 35, Iss. suppl 2, pp. S92-S100
Open Access | Times Cited: 82
Advances in the studies of roles of Rho/Rho-kinase in diseases and the development of its inhibitors
Ronggui Guan, Xiaoyu Xu, Meihui Chen, et al.
European Journal of Medicinal Chemistry (2013) Vol. 70, pp. 613-622
Closed Access | Times Cited: 78
Substance P Exacerbates Dopaminergic Neurodegeneration through Neurokinin-1 Receptor-Independent Activation of Microglial NADPH Oxidase
Qingshan Wang, Chun‐Hsien Chu, Qian Li, et al.
Journal of Neuroscience (2014) Vol. 34, Iss. 37, pp. 12490-12503
Open Access | Times Cited: 77
Page 1 - Next Page

Scroll to top